Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy

Hepatology

Volumn 24, Issue 3, 1996, Pages 580-587

  Portincasa, Piero ^a,b   Van Erpecum, Karel J ^a,c,d   Van De Meeberg, Paul C ^a   Dallinga Thie, Geesje M ^a   De Bruin, Tjerk W A ^a,e   Van Berge Henegouwen, Gerard P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^e Dutch Heart Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FOLLOW UP; GALLBLADDER EMPTYING; GALLBLADDER MOTILITY; GALLSTONE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 0029816911     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008781328     Document Type: Article

References (61)

1. Sackmann M, Delius M, Sauerbruch T, Holl J, Weber W, Ippisch E, Haqelauer U, et al. Shock-wave lithotripsy of gallbladder stones, the first 175 patients. N Engl J Med 1988;318:393-397.
2. Sackmann M, Pauletzki J, Sauerbruch T, Holl J, Schelling G, Paumgartner G. The Munich gallbladder lithotripsy study: results of the first 5 years with 711 patients. Ann Intern Med 1991;114:290-296.
3. Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, Barbara L, et al. Gallstone recurrence after successful oral bile acid treatment: a 12 year follow-up study and evaluation of long term postdissolution treatment. Gastroenterology 1989;97:726-731.
4. O'Donnell LDJ, Heaton KW. Recurrence and re-recurrence of gallstones after medical dissolution: a longterm follow-up. Gut 1988;29:655-658.
5. Groen AK, Noordam C, Drapers JAG, Egbers P, Jansen PLM, Tytgat GNJ. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile of patients with solitary or multiple cholesterol gallstones. HEPATOLOGY 1990;11:525-533.
6. Drapers JAG, Groen AK, Stout JPJ, Noordam C, Hoek FJ, Jansen PLM, Tytgat GNJ. Quantification of cholesterol nucleation promoting activity in human gallbladder bile. Clin Chim Acta 1987;165:295-302.
7. Kesaniemi YA, Koskenvuo M, Vuoristo M, Miettinen TA. Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut 1989;30: 1750-1756.
8. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
9. Uterman G. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
10. Juvonen T, Kervinen K, Kairaluoma MI, Lajunen LH, Kesaniemi YA. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993;104:1806-1813.
11. Marks JW. Recurrence of gallstones following nonsurgical therapy with extracorporeal shock-wave lithotripsy. Gastroenterology 1994;106:262-264.
12. Sackmann M, Ippisch E, Sauerbruch T, Holl J, Brendel W, Paumgartner G. Early gallstone recurrence rate after successful shock-wave therapy. Gastroenterology 1990;98:392-396.
13. Sackmann M, Niller H, Ippisch E, Klueppelberg U, von Ritter C, Pauletzki J, Holl J, et al. Gallstone recurrence after shock-wave therapy. Gastroenterology 1994;106:225-230.
14. Sackmann M, Eder H, Spengler U, Pauletzki J, Holl J, Paumgartner G, Sauerbruch T. Gallbladder emptying is an important factor in fragment disappearance after shock wave lithotripsy. J Hepatol 1993;17:62-66.
15. Pauletzki J, Sailer C, Klueppelberg U, von Ritter C, Neubrand M, Holl J, Sauerbruch T, et al. Gallbladder emptying determines early gallstone clearance after shock-wave lithotripsy. Gastroenterology 1994;107:1496-1502.
16. Berr F, Mayer M, Sackmann M, Sauerbruch T, Holl J, Paumgartner G. Pathogenic factors in early recurrence of cholesterol gallstones. Gastroenterology 1994;106:215-224.
17. Hood K, Gleeson D, Ruppin DC, Dowling RH. Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs. Lancet 1988;2:1223-1225.
18. Hood KA, Gleeson D, Ruppin DC, Dowling RH, British-Belgian Gall Stone Study Group. Gallstone recurrence and its prevention: the British/Belgian gallstone study group's post-dissolution trial. Gut 1993;34:1277-1288.
19. Adamek HE, Buttmann A, Weber J, Riemann JF. Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy? Scand J Gastroenterol 1994;29:355-359.
20. Dallinga-Thie GM, van Linde-Sibenius M, Kock LAW, De Bruin TWA. Apolipoprotein E2/E3/E4 genotyping with agarose gels. Clin Chem 1995; 41:73-75.
21. Smit M, de Knijff P, Rosseneu M, Bury J, Klasen E, Frants R, Havekes LM. Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 1988;80:287-292.
22. Everson GT, Braverman DZ, Johnson ML, Kern F Jr. A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 1980;79:40-46.
23. Van Erpecum KJ, vanBerge-Henegouwen GP, Stolk MFJ, Hopman WPM, Jansen JBMJ, Lamers CBHW. Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects. Gastroenterology 1990;99:836-842.
24. Portincasa P, Di Ciaula A, Baldassarre G, Palmieri V, Gentile A, Cimmino A, Palasciano G. Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. J Hepatol 1994;21:430-440.
25. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Cambridge: Blackwell Scientific Pub, 1987:296.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
27. Strasberg SM, Clavien PA. Cholecystolithiasis: lithotherapy for the 1990s. HEPATOLOGY 1992;16:820-839.
28. Schoenfield LJ, Berci PDG, Carnovale RL. The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones: the Dornier National Biliary Lithotripsy Study. N Engl J Med 1990;323: 1239-1245.
29. Greiner L, Munks C, Heil W, Jakobeit C. Gallbladder stone fragments in feces after biliary extracorporeal shock wave lithotripsy. Gastroenterology 1990;98:1620-1624.
30. Van Erpecum KJ, vanBerge-Henegouwen GP, Stolk MFJ, Hopman WPM, Jansen JBMJ, Lamers CBHW. Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects. J Hepatol 1992;14:194-202.
31. Spengler U, Sackmann M, Sauerbruch T, Holl J, Paumgartner G. Gallbladder motility before and after extracorporeal shock-wave lithotripsy. Gastroenterology 1989;96:860-863.
32. Ziegenhagen DJ, Zehnter E, Kruis W, Pohl C. Induced gallbladder contraction accelerates fragment clearance after extracorporeal shockwave lithotripsy. J Gastroenterol Hepatol 1993;8:406-409.
33. O'Donnell LJ, Wilson P, Guest P, Catnach SM, McLean A, Wickham JE, Fairclough PD. Indomethacin and postprandial gallbladder emptying. Lancet 1992;339:269-271.
34. Catnach SM, Fairclough PD, Trembath RC, O'Donnell LJ, McLean AM, Law PA, Wickham JE. Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones. Gastroenterology 1992; 102:2071-2076.
35. Marzio L, Neri M, De Angelis C, di Felice F, Celiberti V, Pieramico O, Mezzetti A, et al. Effect of cisapride on gallbladder kinetics in normals and patients with decreased gallbladder response to a liquid meal. Curr Ther Res 1987;42:895-900.
36. Portincasa P, Di Ciaula A, Palmieri V, Baldassarre G, Palasciano G. Enhancement of gallbladder emptying in gallstone patients after oral cholestyramine. Am J Gastroenterol 1994;6:909-914.
37. Nitsche R, Schweinsberg V, Klengel H, Niedmann P, Folsch U. Different modes of fragmenting gallstones in extracorporeal shockwave lithotripsy. Scand J Gastroenterol 1993;28:229-234.
38. Everson GT, McKinley C, Lawson M, Johnson M, Kern F. Gallbladder function in human females: effect of the ovulatory cycles, pregnancy and contraceptive steroids. Gastroenterology 1982;82:711-719.
39. Gordon SJ, Torres WE, Mendez L, Evans G, Taglienti G. Effect of estrogen (E)/progesterone (P) therapy on gallstone fragment clearance post shockwave lithotripsy [Abstract]. Gastroenterology 1991;101:317.
40. Buttmann A, Adamek HE, Weber J, Riemann JF. ESWL and oral dissolution therapy: what factors influence results. Dig Dis Sci 1993;38:1702-1711.
41. Gleeson D, Ruppin CD, Saunders A, Murphy GM, Dowling RH. Final outcome of ursodeoxycholic treatment in 126 patients with radiolucent gallstones. Q J Med 1990;76:711-729.
42. Sackmann M, Aydemir U, Pauletzki J, Hasford J, Sauerbruch T, Holl J, Paumgartner G. Factors determinating gallbladder clearance after shockwave lithotripsy [Abstract]. HEPATOLOGY 1990;12:734.
43. Schoenfield LJ, Marks JW, for the National Cooperative Gallstone Study Group. Update on results of the National Cooperative Gallstone Study: chenodiol after partial gallstone dissolution and gallstone recurrence after dissolution. In: Barbara L, et al. eds. Recent advances in bile acid research. New York: Raven, 1985:267-271.
44. Lanzini A, Jazrawi RP, Kupfer RM, Maudgal DP, Joseph AEA, Northfield TC. Gallstone recurrence after medical dissolution. An overestimated threat? J Hepatol 1986;3:241-246.
45. Petroni ML, Jazrawi RP, Lanzini A, Facchinetti D, Heaton KW, Northfield TC. Characteristics of recurrent gallstones following non-surgical treatment: implication for retreatment. Eur J Gastroenterol Hepatol 1991;3: 473-478.
46. Schneider HT, Benninger J, Rabes U, Madani N, May A, Hahn EG, Ell C. Recurrent gallstone formation after successful extracorporeal shockwave lithotripsy. Am J Gastroenterol 1993;88:1399-1404.
47. Pelletier G, Capdeville R, Mosnier H, Raymond JM, Delmont J, Moreaux J, Guivarch M, et al. Low early gallstone recurrence after successful extracorporeal lithotripsy in patients with solitary stones. J Hepatol 1992;16: 102-105.
48. Pelletier G, Raymond JM, Capdeville R, Mosnier H, Caroli-Bosc FX. Gallstone recurrence after successful lithotripsy. J Hepatol 1995;23:420-423.
49. Danzinger RG, Gordon H, Schoenfield LJ, Thistle JL. Lithogenic diet in siblings of young women with cholelithiasis. Mayo Clin Proc 1972;47:762-766.
50. Kesaniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency is related to apolipoprotein E phenotype. J Clin Invest 1987; 80:578-581.
51. Angelin B, Holmqvist L, Leijd B, Einarsson K. Bile acid metabolism in familial dysbetalipoproteinemia: studies in subjects with the apolipoprotein E2/2 phenotype. Eur J Clin Invest 1990;20:143-149.
52. Terkeltaub RA, Dyer CA, Martin J, Curtiss LK. Apolipoprotein (Apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular Apo E and demonstration of Apo E binding to urate crystals in vivo. J Clin Invest 1991;87:20-26.
53. Lee SP, Carey MC, LaMont JT. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981;211:1429-1431.
54. Rhodes M, Allen A, Lennard TWJ. Mucus glycoprotein biosynthesis in the human gallbladder: inhibition by aspirin. Gut 1992;33:1109-1112.
55. Rhodes M, Allen A, Dowling RH, Murphy G, Lennard TW. Inhibition of human gallbladder mucus synthesis in patients undergoing cholecystectomy. Gut 1992;33:1113-1117.
56. Cohen BI, Mosbach EH, Ayyad N, Yoshii M, McSherry CK. Aspirin does not inhibit cholesterol lithiasis in two established animal models. Gastroenterology 1991;101:1109-1116.
57. O'Leary DP, LaMorte WW, Scott TE, Booker ML, Stevenson J. Inhibition of prostaglandin synthesis fails to prevent gallbladder mucin hypersecretion in the cholesterol-fed prairie dog. Gastroenterology 1991;101:812-820.
58. Marks JW, Lan SP, The Steering Committee, and The National Cooperative Gallstone Study Group. Low-dose chenodiol to prevent gallstone recurrence after dissolution therapy. Ann Intern Med 1984;100:376-381.
59. Jorgensen T. Abdominal symptoms and gallstone disease: an epidemiological investigation. HEPATOLOGY 1989;9:856-860.
60. Palasciano G, Portincasa P, Belfiore A, Baldassarre G, Cignarelli M, Paternostro A, Albano O, et al. Gallbladder volume and emptying in diabetics: the role of neuropathy and obesity. J Intern Med 1992;231:123-127.
61. Palasciano G, Serio G, Portincasa P, Palmieri V, Fanelli M, Velardi ALM, Calo' Gabrieli B, et al. Gallbladder volume in adults and relationship to age, sex, body mass index and gallstones: a sonographic population study. Am J Gastroenterol 1992;87:493-497.